Funder: NIH National Institute on Deafness and Other Communication Disorders (NIDCD)

ASC-related symptoms are wide ranging, and can have cardiopulmonary, gastrointestinal, dermatologic, endocrine, psychiatric and/or neurological manifestations, including sensory dysfunction and cognitive-communication difficulties. Further research is critical to understand the symptomatology, pathogenesis, and underlying mechanisms of PASC. NIDCD invites applications for research on PASC in relation to NIDCD’s scientific programs of hearing, balance, taste, smell, voice, speech and language. When appropriate, NIDCD encourages multi-disciplinary approaches to move the research beyond in vitro and animal models.

Topics: Biomarkers, Clinical Presentation of Infection, ARDS, Cellular / Molecular Response, Inflammation, Long-term Impact of Infection, Pneumonia, Sensory, Clinical Trial, Co-Morbidities, COVID-19, Immune Disorders, Inflammation, Neurological Disorders, ELSI (Ethical, Legal, and Social Implications), Environmental Health, Epidemiology, Clinical History, Clinical Outcome, Contact Tracing, Incidence, Risk Factors, Health Disparities, Healthcare Implementation, Immunity, Immunology, Host Factors, Host Response, Mobile Health, App, Telemedicine, Wearables, Oral Science / Dentistry, Organ, Brain, Oral Cavity, Prognostics, Research Methods, Cell Culture, Electronic Health Records (EHR), Imaging, Immunofluorescence, Screen, Sequencing, Research Site, Community-based, Virology, Viral Interactome, Viral Proteins, Target Population, Deaf Persons